相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low RAI2 expression is a marker of poor prognosis in breast cancer
Sayaka Nishikawa et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer
Rokaya El Ansari et al.
BRITISH JOURNAL OF CANCER (2020)
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer
Lutfi H. Alfarsi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma
Maihulan Maimaiti et al.
SCIENTIFIC REPORTS (2020)
The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER plus breast cancer
Rokaya El-Ansari et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer
Yasuhiro Saito et al.
NATURE (2019)
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma
Kosuke Higuchi et al.
SCIENTIFIC REPORTS (2019)
Amino Acid Transporters and Glutamine Metabolism in Breast Cancer
Yoon Jin Cha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours
Rokaya El Ansari et al.
BREAST CANCER RESEARCH (2018)
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
Zsuzsanna Mihaly et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
A new genome-driven integrated classification of breast cancer and its implications
Sarah-Jane Dawson et al.
EMBO JOURNAL (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Mammostrat As an Immunohistochemical Multigene Assay for Prediction of Early Relapse Risk in the Tamoxifen Versus Exemestane Adjuvant Multicenter Trial Pathology Study
John M. S. Bartlett et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Age-Dependent Carcinogenic Susceptibility in Rat Liver Is Related to Potential of Gap Junctional Intercellular Communication
Aya Naiki-Ito et al.
TOXICOLOGIC PATHOLOGY (2012)
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Cesar G. Sanchez et al.
BREAST CANCER RESEARCH (2011)
Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors
T. John et al.
ONCOGENE (2009)
Biologic and clinical characteristics of breast cancer with single hormone receptor-positive phenotype
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors
Hiroshi Nawashiro et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization:: a technical review with interpretive guidelines
DG Hicks et al.
HUMAN PATHOLOGY (2005)
HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: A southwest oncology group study
G Arpino et al.
CLINICAL CANCER RESEARCH (2004)
HER-2/neu analysis in archival tissue samples of human breast cancer:: Comparison of immunohistochemistry and fluorescence in situ hybridization
A Lebeau et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
